ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1001

Perceived Mistreatment in Patients with Rheumatic Diseases: The Impact of the Underlying Diagnosis

Virginia Pascual Ramos1, Guillermo Guaracha Basañez2, Irazú Contreras-Yáñez3, Loraine Ledón-LLanes4, Ana Ortiz-Haro4 and Guillermo A Guaracha-Basañez4, 1Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Federal District, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirón", Mexico City, Mexico, 3Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico city, Mexico, 4Instituto Nacional de Ciencias Medicas y Nutricion “Salvador Zubirán”, Mexico City, Distrito Federal, Mexico

Meeting: ACR Convergence 2024

Keywords: Epidemiology, ethics, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Mistreatment is a complex problem that impacts people’s quality of life, morbidity, and mortality. In aged people, it has been associated with female sex, poor general health, depression, functional decline, and increased dependence levels, all of which are well-recognized characteristics of patients with rheumatic diseases (RMDs). 

The objective was to describe the mistreatment phenomenon in Mexican patients with RMDs. We additionally report the adaptation and validation of the Geriatric Mistreatment Scale (GMS) in the target population. 

Methods: This cross-sectional study was developed in two phases (June 2023- February 2024), and three convenience samples were used: S-1 (n=30), S-2 (n=260), and S-3 (n=372).

Phase 1 consisted of first adapting the GMS (22 items distributed across five dimensions: physical, psychological, neglect, economic, and sexual, and each item allowed a dichotomous-type response [no occurrence/occurrence]) to RMDs (RMD-MS), using experts’ judgment. After that, we performed RMD-MS face validity (pilot testing, S-1), content validity (experts’ agreement), concurrent criterion validity (with family APGAR score ≤3, S-2), construct validity (exploratory factor analysis and convergent validity, S-2), reliability (internal consistency and temporal stability, S-2) and feasibility (in S-1).

Phase 2 consisted of the mistreatment description in S-3.

The RMD-MS score was calculated as the sum of the individual item’s score (min 0-Max 25), and the final score is presented on a scale of 0 to 10. Mistreatment was defined when RMD-MS score ≥1.

The sample size required to estimate overall mistreatment was (at least) 365 patients, with a 95% confidence level and 5% precision.

Results: Overall, patients represented typical outpatients with RMDs and substantial disease duration (Table 1). The Figure summarizes the most frequent diagnoses in the three samples used.

There were 187 (50.3%) patients with overall mistreatment, and psychological mistreatment was the most frequent in 142 (75.9%) patients, followed by neglect in 96 (51.3%), sexual in 30 (16%), physical in 23 (12.3%), and economic mistreatment in 20 (10.7%). Among patients who rated mistreatment, they perceived it was related to the underlying RMD or RMD impact on their lives and families in a variable percentage, from 13.3% for sexual mistreatment to 53.3% for psychological mistreatment.

Patients with a positive answer to at least one mistreatment pattern were selected to identify the sex and the relationship with the abuser. The number of “I do not want to answer” responses raised to 21.7%-67.7% for sex identification and 40% to 72.9% for the relationship with the patient. Overall, men (for neglect, economic, and sexual mistreatment patterns) and family members (all mistreatment patterns but for psychological mistreatment) were frequently identified as abusers.

The RMD-MS scale was valid, reliable, and feasible (Table 2).

Conclusion: Half of the Mexican patients with RMDs perceived some mistreatment, most frequently psychological mistreatment, which is also often perceived as related to the underlying RMD.

Supporting image 1

Data are presented as number of patients, %. SLE=Systemic Lupus Erythematosus. RA=Rheumatoid Arthritis. SS=Systemic Sclerosis. SV=Systemic Vasculitis. PSS=Primary Sjögren Syndrome. SA=Spondyloarthritis. IM=Inflammatory Myopathies. PAPS=Primary Anti-phospholipid Syndrome. MCTD=Mixed Connective Tissue Disease. ASD=Adult Onset-Still disease.

Supporting image 2

Data presented as median (Q25-Q75) as otherwise indicated. *Number (%) of patients. ¹Among those who met the characteristic.2Lovibond SH, Lovibond PF. Manual for the Depression Anxiety & Stress Scales. 2nd ed. Sydney: Psychology Foundation; 1995

Supporting image 3


Disclosures: V. Pascual Ramos: None; G. Guaracha Basañez: None; I. Contreras-Yáñez: None; L. Ledón-LLanes: None; A. Ortiz-Haro: None; G. Guaracha-Basañez: None.

To cite this abstract in AMA style:

Pascual Ramos V, Guaracha Basañez G, Contreras-Yáñez I, Ledón-LLanes L, Ortiz-Haro A, Guaracha-Basañez G. Perceived Mistreatment in Patients with Rheumatic Diseases: The Impact of the Underlying Diagnosis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/perceived-mistreatment-in-patients-with-rheumatic-diseases-the-impact-of-the-underlying-diagnosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perceived-mistreatment-in-patients-with-rheumatic-diseases-the-impact-of-the-underlying-diagnosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology